House File No. 1011 is a legislative bill that aims to make changes in the scope of practice for optometrists in Minnesota. The bill intends to update the regulations related to the types of drugs that optometrists can prescribe and administer, as outlined in Minnesota Statutes 2024, section 148.56, subdivision 1.

Here are the primary changes proposed in the bill:

1. Prescription of Lenses and Prisms: Optometrists can prescribe lenses and prisms for visual correction.

2. Use of Legend Drugs: Optometrists will be allowed to prescribe or administer legend drugs (prescription drugs that require a label) to help diagnose, treat, prevent, or manage eye diseases and conditions. This is limited to the training provided in accredited optometry schools and further restricted by guidelines set by the Minnesota Board of Optometry.

3. Restrictions on Drug Administration:

   • Optometrists cannot administer drugs intravenously, intramuscularly, or by injection, except for treating anaphylaxis or specific eye procedures like sub-Tenon, retrobulbar, or intravitreal injections.
   • Optometrists are prohibited from performing invasive surgeries, including surgeries involving lasers.
   • Optometrists cannot prescribe or administer Schedule II and III oral drugs and oral steroids or oral antiviral medications for periods exceeding specific durations without physician consultation.

These changes are intended to adjust and clarify the responsibilities and capabilities of optometrists in treating eye-related health issues while ensuring safety and regulatory compliance. The proposal reflects an effort to modernize the field's practice standards in line with current needs and technological advancements.